StockWatch
·
Pharmaceuticals
USFDA28 Oct 2026, 06:30 pm

Dr Reddy's USFDA Inspection Closed as Voluntary Action Indicated (VAI)

AI Summary

Dr Reddy's Laboratories Ltd has announced that the United States Food & Drug Administration (USFDA) has concluded its inspection of the company's FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh. The inspection, which included a Pre-Approval Inspection (PAI) and Good Manufacturing Practices (GMP) assessment, has been officially closed with a 'Voluntary Action Indicated (VAI)' classification. This outcome indicates that while some observations may have been made, they do not warrant a regulatory enforcement action at this time and the facility is considered compliant.

Key Highlights

  • USFDA inspection at Srikakulam unit concluded.
  • Inspection classified as 'Voluntary Action Indicated' (VAI).
  • The USFDA has officially closed the inspection.
  • This outcome is positive for the company's manufacturing compliance.